SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-083528
Filing Date
2021-06-21
Accepted
2021-06-21 16:34:35
Documents
14
Period of Report
2021-06-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2120148-1_8k.htm   iXBRL 8-K 42369
2 EXHIBIT 99.1 tm2120148d1_ex99-1.htm EX-99.1 579559
  Complete submission text file 0001104659-21-083528.txt   889751

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mrk-20210621.xsd EX-101.SCH 4498
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20210621_def.xml EX-101.DEF 28712
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20210621_lab.xml EX-101.LAB 38996
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20210621_pre.xml EX-101.PRE 27321
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2120148-1_8k_htm.xml XML 8752
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 211031184
SIC: 2834 Pharmaceutical Preparations